Logo image of QXO

QXO INC (QXO) Stock Fundamental Analysis

NYSE:QXO - US82846H4056 - Common Stock

20.9999 USD
+0.61 (+2.99%)
Last: 8/25/2025, 1:29:06 PM
Fundamental Rating

3

Overall QXO gets a fundamental rating of 3 out of 10. We evaluated QXO against 48 industry peers in the Trading Companies & Distributors industry. The financial health of QXO is average, but there are quite some concerns on its profitability. QXO is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year QXO was profitable.
QXO had a negative operating cash flow in the past year.
QXO Yearly Net Income VS EBIT VS OCF VS FCFQXO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of QXO (-0.67%) is worse than 70.83% of its industry peers.
Looking at the Return On Equity, with a value of -1.15%, QXO is doing worse than 70.83% of the companies in the same industry.
Industry RankSector Rank
ROA -0.67%
ROE -1.15%
ROIC N/A
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-5.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QXO Yearly ROA, ROE, ROICQXO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Gross Margin value of 21.49%, QXO is not doing good in the industry: 72.92% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of QXO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for QXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5YN/A
QXO Yearly Profit, Operating, Gross MarginsQXO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

More info and screens

4

2. Health

2.1 Basic Checks

QXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
QXO has more shares outstanding than it did 1 year ago.
The debt/assets ratio for QXO has been reduced compared to a year ago.
QXO Yearly Shares OutstandingQXO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 100M 200M 300M 400M
QXO Yearly Total Debt VS Total AssetsQXO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

QXO has an Altman-Z score of 1.53. This is a bad value and indicates that QXO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of QXO (1.53) is worse than 75.00% of its industry peers.
QXO has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, QXO perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 1.53
ROIC/WACCN/A
WACC9.65%
QXO Yearly LT Debt VS Equity VS FCFQXO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 3.00 indicates that QXO has no problem at all paying its short term obligations.
The Current ratio of QXO (3.00) is better than 79.17% of its industry peers.
A Quick Ratio of 2.15 indicates that QXO has no problem at all paying its short term obligations.
QXO has a better Quick ratio (2.15) than 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 2.15
QXO Yearly Current Assets VS Current LiabilitesQXO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

8

3. Growth

3.1 Past

QXO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.22%, which is quite impressive.
The Revenue has grown by 3310.76% in the past year. This is a very strong growth!
QXO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.90% yearly.
EPS 1Y (TTM)98.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.5%
Revenue 1Y (TTM)3310.76%
Revenue growth 3Y10.9%
Revenue growth 5YN/A
Sales Q2Q%13011.42%

3.2 Future

The Earnings Per Share is expected to grow by 95.53% on average over the next years. This is a very strong growth
QXO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 240.81% yearly.
EPS Next Y701.12%
EPS Next 2Y228.27%
EPS Next 3Y149.02%
EPS Next 5Y95.53%
Revenue Next Year12636.9%
Revenue Next 2Y1333.28%
Revenue Next 3Y554.35%
Revenue Next 5Y240.81%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QXO Yearly Revenue VS EstimatesQXO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
QXO Yearly EPS VS EstimatesQXO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 131.25, the valuation of QXO can be described as expensive.
Based on the Price/Earnings ratio, QXO is valued a bit more expensive than 75.00% of the companies in the same industry.
QXO is valuated expensively when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 39.49, the valuation of QXO can be described as expensive.
Based on the Price/Forward Earnings ratio, QXO is valued a bit more expensive than the industry average as 72.92% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.81, QXO is valued quite expensively.
Industry RankSector Rank
PE 131.25
Fwd PE 39.49
QXO Price Earnings VS Forward Price EarningsQXO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QXO Per share dataQXO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

QXO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QXO's earnings are expected to grow with 149.02% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y228.27%
EPS Next 3Y149.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QXO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QXO INC

NYSE:QXO (8/25/2025, 1:29:06 PM)

20.9999

+0.61 (+2.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners61.48%
Inst Owner Change73.62%
Ins Owners0.05%
Ins Owner Change0.18%
Market Cap14.14B
Analysts89.09
Price Target32.9 (56.67%)
Short Float %4.78%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.24
Dividend Growth(5Y)N/A
DP-67.51%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.11%
Min EPS beat(2)40.59%
Max EPS beat(2)161.62%
EPS beat(4)4
Avg EPS beat(4)118.62%
Min EPS beat(4)23.76%
Max EPS beat(4)248.52%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.08%
Min Revenue beat(2)0.71%
Max Revenue beat(2)11.45%
Revenue beat(4)3
Avg Revenue beat(4)2.36%
Min Revenue beat(4)-6.97%
Max Revenue beat(4)11.45%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.01%
PT rev (3m)N/A
EPS NQ rev (1m)-7.58%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.52%
EPS NY rev (3m)400.56%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.81%
Revenue NY rev (3m)179.12%
Valuation
Industry RankSector Rank
PE 131.25
Fwd PE 39.49
P/S 7.26
P/FCF N/A
P/OCF N/A
P/B 1.43
P/tB 18.28
EV/EBITDA N/A
EPS(TTM)0.16
EY0.76%
EPS(NY)0.53
Fwd EY2.53%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS2.89
BVpS14.72
TBVpS1.15
PEG (NY)0.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.67%
ROE -1.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.49%
FCFM N/A
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-5.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.3%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3
Quick Ratio 2.15
Altman-Z 1.53
F-Score3
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)12.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.5%
EPS Next Y701.12%
EPS Next 2Y228.27%
EPS Next 3Y149.02%
EPS Next 5Y95.53%
Revenue 1Y (TTM)3310.76%
Revenue growth 3Y10.9%
Revenue growth 5YN/A
Sales Q2Q%13011.42%
Revenue Next Year12636.9%
Revenue Next 2Y1333.28%
Revenue Next 3Y554.35%
Revenue Next 5Y240.81%
EBIT growth 1Y-33288.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1099.73%
EBIT Next 3Y200.72%
EBIT Next 5Y113.57%
FCF growth 1Y18215.2%
FCF growth 3Y813.27%
FCF growth 5YN/A
OCF growth 1Y14439.7%
OCF growth 3Y621.5%
OCF growth 5YN/A